Opus Genetics (IRD) Return on Equity [ROE] (2011 - 2025)
Opus Genetics' Return on Equity [ROE] came in at -465.32% for Q4 2025, down 184.84 percentage points from -280.48% a year earlier but up 116.62 percentage points from the prior quarter.
Powered by 
Analysis
Opus Genetics (IRD) Return on Equity [ROE] (2011 - 2025) Analysis & Trends
For FY2025, Opus Genetics' Return on Equity [ROE] was -449.36%, down 246.17 percentage points from FY2024.
- Return on Equity [ROE] has declined in each of the last three years, though with a four-year change of +845.74 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was -203.19% in FY2024 (-182.41 pp), -20.77% in FY2023 (-73.03 pp), 52.26% in FY2022 (+1347.36 pp) and -1295.10% in FY2021.
- The five-year range for quarterly Return on Equity [ROE] is -993.81% (Q1 2025) to 65.35% (Q3 2023).
- Year-over-year, Return on Equity [ROE] has declined for nine consecutive quarters, with an average year-over-year change of -336.68 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2022 (a gain of 326.55 percentage points), and the weakest in Q1 2025 (a drop of 970.26 percentage points).
- Business Quant data shows IRD's Return on Equity [ROE] at -581.94% (Q3 2025), -516.94% (Q2 2025) and -993.81% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Opus Genetics | 400.02 Mn | 175.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -465.32% |
| Sep 30, 2025 | -581.94% |
| Jun 30, 2025 | -516.94% |
| Mar 31, 2025 | -993.81% |
| Dec 31, 2024 | -280.48% |
| Sep 30, 2024 | -72.57% |
| Jun 30, 2024 | -32.54% |
| Mar 31, 2024 | -23.55% |
| Dec 31, 2023 | -19.93% |
| Sep 30, 2023 | 65.35% |
| Jun 30, 2023 | 47.26% |
| Mar 31, 2023 | 42.73% |
| Dec 31, 2022 | 61.56% |
| Sep 30, 2022 | -168.98% |
| Jun 30, 2022 | -138.48% |
| Mar 31, 2022 | -122.93% |
| Dec 31, 2021 | -264.99% |
| Sep 30, 2021 | -320.32% |
| Jun 30, 2021 | -408.28% |
| Dec 31, 2019 | -184.94% |
API Access
Opus Genetics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();